Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.
2.

Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.

Kanzaki G, Nagasaka S, Higo S, Kajimoto Y, Kanemitsu T, Aoki M, Nagahama K, Natori Y, Tsuboi N, Yokoo T, Shimizu A.

Nephrol Dial Transplant. 2016 Apr;31(4):574-85. doi: 10.1093/ndt/gfv384. Epub 2015 Nov 17.

PMID:
26582929
3.

Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.

Hoshino A, Nagao T, Ito-Ihara T, Ishida-Okawara A, Uno K, Muso E, Nagi-Miura N, Ohno N, Tokunaka K, Naoe S, Hashimoto H, Yasuhara M, Yamamoto K, Suzuki K.

Microbiol Immunol. 2007;51(5):551-66.

4.

Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.

van der Veen BS, Petersen AH, Belperio JA, Satchell SC, Mathieson PW, Molema G, Heeringa P.

Clin Exp Immunol. 2009 Oct;158(1):143-53. doi: 10.1111/j.1365-2249.2009.03993.x.

5.

Reduction of MPO-ANCA epitopes in SCG/Kj mice by 15-deoxyspergualin treatment restricted by IgG2b associated with crescentic glomerulonephritis.

Tomizawa K, Nagao T, Kusunoki R, Saiga K, Oshima M, Kobayashi K, Nakayama T, Tanokura M, Suzuki K.

Rheumatology (Oxford). 2010 Jul;49(7):1245-56. doi: 10.1093/rheumatology/keq087. Epub 2010 Apr 8.

PMID:
20378710
6.

Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.

Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Sasaki T, Suzuki K.

Clin Nephrol. 1993 Nov;40(5):256-64.

PMID:
8281714
7.

Genetic dissection of vasculitis, myeloperoxidase-specific antineutrophil cytoplasmic autoantibody production, and related traits in spontaneous crescentic glomerulonephritis-forming/Kinjoh mice.

Hamano Y, Tsukamoto K, Abe M, Sun GD, Zhang D, Fujii H, Matsuoka S, Tanaka M, Ishida-Okawara A, Tachikawa H, Nishimura H, Tokunaka K, Hirose S, Suzuki K.

J Immunol. 2006 Mar 15;176(6):3662-73.

8.

Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.

Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, Hickey MJ, Holdsworth SR.

J Am Soc Nephrol. 2006 Jul;17(7):1940-9. Epub 2006 Jun 12.

9.

Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.

Gan PY, Holdsworth SR, Kitching AR, Ooi JD.

Cell Immunol. 2013 Mar;282(1):21-7. doi: 10.1016/j.cellimm.2013.04.007. Epub 2013 Apr 25.

PMID:
23665205
10.

A novel mouse model for MPO-ANCA-associated glomerulonephritis.

Yumura W, Itabashi M, Ishida-Okawara A, Tomizawa K, Yamashita J, Kaneshiro Y, Nihei H, Suzuki K.

Microbiol Immunol. 2006;50(2):149-57.

11.

Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.

Hamano Y, Abe M, Matsuoka S, Zhang D, Kondo Y, Kagami Y, Ishigami A, Maruyama N, Tsuruta Y, Yumura W, Suzuki K.

Clin Exp Immunol. 2014 Jul;177(1):353-65. doi: 10.1111/cei.12333.

12.

Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.

Suzuki K, Kobayashi S, Yamazaki K, Gondo M, Tomizawa K, Arimura Y, Nakabayashi K, Ozaki S, Yoshida M, Yoshida T, Tsusaka N, Muso E, Okazaki T, Hashimoto H.

Microbiol Immunol. 2007;51(12):1215-20.

13.

[Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].

Arranz O, Ara J, Rodríguez R, Poveda R, Serra A, Solé-Amigó J, Fort J, Mirapeix E, Darnell A.

Nefrologia. 2001 Jul-Aug;21(4):349-54. Spanish.

14.

Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.

Suzuki K, Suzuki K, Nagao T, Nakayama T.

Clin Exp Nephrol. 2013 Oct;17(5):638-641. doi: 10.1007/s10157-013-0861-1. Epub 2013 Sep 27. Review.

PMID:
24072414
15.

MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.

Murakami T, Nagai K, Matsuura M, Kondo N, Kishi S, Araoka T, Kishi F, Sakiyama T, Mima A, Bando Y, Abe H, Doi T.

Ren Fail. 2011;33(6):626-31. doi: 10.3109/0886022X.2011.581401. Epub 2011 May 20.

PMID:
21599422
16.
17.

Significance of myeloperoxidase in rapidly progressive glomerulonephritis.

Saeki T, Kuroda T, Morita T, Suzuki K, Arakawa M, Kawasaki K.

Am J Kidney Dis. 1995 Jul;26(1):13-21.

PMID:
7611243
18.

Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.

Ishida-Okawara A, Ito-Ihara T, Muso E, Ono T, Saiga K, Nemoto K, Suzuki K.

Nephrol Dial Transplant. 2004 Jul;19(7):1708-15. Epub 2004 May 18.

PMID:
15150352
19.

Renal expression of adhesion molecules in anca-associated disease.

Arrizabalaga P, Solé M, Abellana R, Ascaso C.

J Clin Immunol. 2008 Sep;28(5):411-9. doi: 10.1007/s10875-008-9215-2. Epub 2008 Jun 24.

PMID:
18574676
20.

FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.

Ooi JD, Gan PY, Chen T, Eggenhuizen PJ, Chang J, Alikhan MA, Odobasic D, Holdsworth SR, Kitching AR.

Kidney Int. 2014 Dec;86(6):1140-9. doi: 10.1038/ki.2014.189. Epub 2014 May 28.

PMID:
24869670

Supplemental Content

Support Center